Our finding that TWEAK can promote the expression of both TSLP and IL-19 from keratinocytes or dermal fibroblasts provides a further mechanism by which TWEAK can contribute to the development and/or maintenance of the clinical phenotypes of both AD and psoriasis. Here, IL19 is linked to Alzheimer disease.